Fig. 5From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapyCorrelation of anti-Spike IgG, IgA and NAb in HC group (HC: Healthy controls, NAb: Neutralizing antibody)Back to article page